Literature DB >> 19223877

Adding a medicine to the WHO model list of essential medicines.

S P Kishore1, B J Herbstman.   

Abstract

Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. Here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19223877      PMCID： PMC8052985          DOI： 10.1038/clpt.2008.258

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  12 in total

1.  INTER-HEART: A global study of risk factors for acute myocardial infarction.

Authors:  S Ounpuu; A Negassa; S Yusuf
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

Review 2.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

Review 3.  Cardiovascular disease in the developing world and its cost-effective management.

Authors:  Thomas A Gaziano
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

Review 4.  The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world.

Authors:  Bernhard Schwartländer; Ian Grubb; Jos Perriëns
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

5.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study.

Authors:  W M Verschuren; D R Jacobs; B P Bloemberg; D Kromhout; A Menotti; C Aravanis; H Blackburn; R Buzina; A S Dontas; F Fidanza
Journal:  JAMA       Date:  1995-07-12       Impact factor: 56.272

6.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

7.  Total cholesterol and mortality in China, Poland, Russia, and the US.

Authors:  Jianwen Cai; Andrzej Pajak; Yihe Li; Dimitri Shestov; Clarence E Davis; Stefan Rywik; Ying Li; Alexander Deev; Herman A Tyroler
Journal:  Ann Epidemiol       Date:  2004-07       Impact factor: 3.797

8.  Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

Authors:  X Zhang; A Patel; H Horibe; Z Wu; F Barzi; A Rodgers; S MacMahon; M Woodward
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

9.  Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.

Authors:  Yuji Matsuzawa; Toru Kita; Hiroshi Mabuchi; Masunori Matsuzaki; Noriaki Nakaya; Shinichi Oikawa; Yasushi Saito; Jun Sasaki; Kazuaki Shimamoto; Hiroshige Itakura
Journal:  Circ J       Date:  2003-04       Impact factor: 2.993

10.  Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin.

Authors:  W Mück; S Unger; K Kawano; G Ahr
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335
View more
  4 in total

1.  High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.

Authors:  Gregory A Roth; Stephan D Fihn; Ali H Mokdad; Wichai Aekplakorn; Toshihiko Hasegawa; Stephen S Lim
Journal:  Bull World Health Organ       Date:  2010-09-03       Impact factor: 9.408

2.  What is the WHO essential medicines list?

Authors:  M Purgato; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

3.  Enabling access to new WHO essential medicines: the case for nicotine replacement therapies.

Authors:  Sandeep P Kishore; Asaf Bitton; Alejandro Cravioto; Derek Yach
Journal:  Global Health       Date:  2010-11-19       Impact factor: 4.185

Review 4.  A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries.

Authors:  Marc Suhrcke; Till A Boluarte; Louis Niessen
Journal:  BMC Public Health       Date:  2012-01-03       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.